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TREATMENT FOR CONTAGIOUS EQUINE 
METRITIS 
FIELD OF THE INVENTION 
This invention relates to methods for the treatment of 
contagious equine metritis and more particularly to 
novel compositions useful for the treatment of conta 
gious equine metritis by topical application. 
BACKGROUND OF THE INVENTION 
Contagious equine metritis (CEM) is a highly conta 
gious venereal disease of horses caused by a fastidious, 
gram-negative cocobacillus. The disease is character 
ized by a copious water-to-mucopurulent vaginal dis 
charge 2-10 days after breeding by an infected stallion. 
Shortened estrous cycle links are common and may be 
the only indication of endometritis in some instances. 
Carriers of the disease are dif?cult to detect but out 
breaks of the disease have been reported in England, 
Ireland, France, Australia and in the United States. As 
reported by Swaney et a1, American Journal of Veteri 
nary Research, Vol. 41, January, 1980, pps. 127-132, the 
causative agent of contagious equine metritis has been 
identi?ed as Haemophilus equigenitalis, which has ultra 
structural characteristics of gram-negative bacteria. 
The Haemophilus equigenitalis is microaerophilic and 
unreactive biochemically. It does not depend on hemin 
(X factor) or nicotinamide adenine dinucleotide (V 
I factor) for growth although hemin stimulates growth. 
Various proposals have been made for treatment of 
the disease with modest success. Thus, in the article by 
Swaney et a1, there is disclosure that streptomycin can 
be used against the bacteria. Further, in the article by 
‘ John P. Hughes in Theriogenology, published Dec. 8, 
1978, it is reported that a wide range of antibiotic and 
antimicrobial agents have been used either topically, 
parenterally or in combination at varying dose rates and 
over different periods of time. Included are suggestions 
for the use of intrauterine antiseptic solutions, washing 
with surgical soap, rinsing and applying 0.3% nitrofura 
zone ointments and the like but the most common treat 
ment is indicated as being the intrauterine infusion of 
benzyl penicillin or ampicillin‘ for a period of 3 to 5 
days. ' ' 
In the article by Henry J. Dabemat' et al in Antimi 
crobial Agents and Chemotherapy, December 1980, 
pps. 841-843, a review of this disease is‘disclosed with 
the statement that the most active‘drugs are ampicillin, 
gentamicin, and tetracycline, although a number of 
other materials were tested with negative results. In an 
article by S. P. Sahu et al appearing in American Jour 
nal of Veterinary Research, Vol. 41, September 1980, 
pps. 1379-1382, there'is described a review of the dis 
ease and the use of a citrate-phosphate buffer for a sugar 
compound to isolate and identify the bacteria but not as 
a method of treatment. ‘ 
It is evident from this literature that there remains a 
need in the art for a simple, effective method for the 
treatment of animals infected with this disease and the 
present invention provides compositions and methods 
which are effective for this purpose. 
SUMMARY OF THE INVENTION 
It is accordingly one object of the present invention 
to provide a composition which is effective for the 
treatment of contagious equine metritis. 
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A further object of the invention is to provide a 
method for the treatment of contagious equine metritis. 
A still further object of the present invention is to 
provide a topical composition and methods for its use in 
the treatment of contagious equine metritis in horses. 
Other objects and advantages of the present invention 
will become apparent to those skilled in the art as th 
description thereof proceeds. ' 
In satisfaction of the foregoing objects and advan 
tages there is provided by this invention a composition 
for the treatment of contagious equine metritis which 
comprises an aqueous solution of dextrose or a dextrose 
metabolite, a buffering mixture of weak organic acids 
and alkali metal salts of weak organic acids, and a car 
rier, the composition being characterized as a viscous 
solution having a pH of about 3.0 to 4.5. Also provided 
by the present invention is a method for application of 
this composition to horses for the treatment of conta 
gious equine metritis which comprises topically apply 
ing an effective amount of the composition to the exter 
nal genitalia of stallions and mares. 
Description of Preferred Embodiments 
As pointed out above, the present invention is con 
cerned with novel compositions and a method for the 
treatment of ‘contagious equine metritis, which is a rela 
tively newly recognized venereal disease in horses, the 
causative organism being Haemophilus equigenitalis. 
The disease is wide-spread throughout the world and 
has also been found to be present in horses in the United 
States. While there are treatments available for- the 
disease as discussed above, primarily ‘by antibiotics, 
these treatments‘ cause irritation to the mucous mem 
branes. Super bacterial infections, primarily pseudomo 
nas infections, are commonly the end results of the prior 
art treatment. 
The present invention provides a novel composition 
of matter which can be applied topically without the 
disadvantages and side effects of the prior art treat 
ments. The composition of the present invention in its 
broadest embodiment comprises an aqueous solution of 
dextrose or a dextrose metabolite, a buffering mixture of 
weak organic acids and/or alkali metal salts of weak 
organic acids, and a carrier, the solution being charac 
terized as a relatively viscous solution having a pH 
ranging from about 3.0 to 4.5. 
In several trials the composition was found to be 
100% effective in curing horses of the disease if used on 
three successive days. By comparison antibiotics cur 
rently used have to be applied for at least 5 days and are 
not 100% effective. 
The most preferred composition may be character 
ized as containing the following formulation in water in 
a concentration of about 40-60 weight percent: 
Ingredient Parts by Weight 
Dextrose 200-300 
Buffering Mixture 40-110 
Carrier 80-1 10 
The dextrose component of the composition is dex 
trose or a dextrose metabolite which is effective to 
inhibit the contagious equine metritis organism. The 
dextrose component is an important ingredient as 'it 
appears that the dextrose or a metabolite of dextrose 
inhibits the contagious equine metritis organism. vAc 
4,483, 
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cordingly, dextrose or equivalent material may be used 
in the composition. 
The buffering mixture is also an important ingredient 
of the composition. A suf?cient amount of buffer should 
be present to provide a resulting solution having a pH of 5 
about 3.0 to 4.5, most preferably in the range of 3.2. Any 
buffer or mixture of buffers can be used for this purpose 
although mixtures of weak organic acids and alkali 
metal salts of organic acids are especially preferred. The 
amount of buffering agent present is also important 
since the total solution should contain about 8 to 15 
weight percent of buffering agents for a suitable compo 
sition. 
The preferred buffering agents are polycarboxylic 
acids, phosphates, and the like which will provide the 
required pH range. The most preferred buffers however 
comprise a mixture of hydroxy polycarboxylic acids 
having about 3 to 8 carbon atoms and their alkali metal 
salts, or mixtures thereof. Preferred organic acids in 
clude citric acid, malic acid, tartronic acid, tartaric acid, 
and mixtures thereof as well as the sodium and potas 
sium salts of the acid. A highly preferred buffering 
system comprises a mixture of citric acid and sodium 
citrate. . . 
It is also preferred that the resulting solution be a 
viscous solution to inhibit drainage from the infected 
organs after topical application. Thus, a carrier vehicle 
is included in the composition to increase the viscosity 
of the solution. Suitable carries include polyalkylene 
glycols, methyl cellulose and the like. The preferred 
carrier vehicle is a lower polyalkylene glycol such as 
glycerine. 
The carrier also provides the proper consistency to 
the composition so that the composition can be used as 
a lubricant in the treatment of animals such as horses. 
Thus, the composition will provide both lubricating 
properties and effectively treat contagious equine metri 
tis on application to horses. 
A preferred formulation is a 401-60 weight percent 
aqueous composition of the following materials: 
15 
20 
25 
5 
40 
Amount-Parts Ingredient 
Dextrose 200-300 45 
Hydroxy carboxylic acid 25-75 
Alkali metal salt of 40—1l0 
Hydroxy carboxylic acid 
Carrier 80-110 
The most preferred composition for use in the present 
invention is as follows: 
Ingredient Amount 
Dextrose 250 grams 55 
Citric Acid 50 grams 
Sodium Citrate 25 grams 
Glycerine 100 ccs. 
Water 400 ccs. 
The resulting composition is in an aqueous solution 
with suf?cient consistency to drain slowly. In use the 
composition is applied topically directly to the external 
genitalia of stallions and mares and preferably is used 
one time each day for at least two successive days. An 65 
effective amount is simply a thorough application of the 
viscous solution to the external genitalia manually. It 
has been found that this method will provide 100% 
85 l 
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effectiveness in curing horses of the contagious equine 
metritis ' organism-caused disease. 
The following example is to illustrate the invention 
but the invention is not to be considered as limited 
thereto. In the Example and throughout the speci?ca 
tion, parts are by weight unless otherwise indicated. 
EXAMPLE 
The following composition was prepared: 
Ingredient Parts by Weight 
Dextrose 250 grams 
Citric Acid 50 grams 
Sodium Citrate, 25 grams 
Glycerine 100 ccs. 
Water 400 ccs. 
The resulting composition was a viscous solution 
having a pH of 3.20. . 
To show the effectiveness of the compound twenty , 
horses were selected for testing. Each of the twenty 
horses was treated with a single treatment of the solu 
tion by manually applying topically directly to the ex, 
ternal genitalia of the horses. From this test, 17 of the 
horses were found to be cured by the single treatment. 
The three horses which were not cured with the single, 
treatment were then treated again with two successive: 
treatments which were found to successfully cure the 
disease. Accordingly, in the ?eld . it is recommended 
that the disease be treated one time per day with appli-, 
cation of the composition on at least two successive 
days. ' . . 
The advantages in use of the composition of the pres 
ent invention in the treatment of contagious equine 
metritis over current therapy and the antibiotics used in 
the prior art are several. Thus, the horses do not have to ‘ 
be scrubbed prior to treatment, the treatment does not 
irritate the mucous membranes and the skin, and the 
treatment does not cause super bacterial infections. 
Moreover, the treatment is effective for pseudomonas 
as well as for the contagious equine metritis organism. 
Moreover, only about two to three treatments'are nec 
essary and mares-can be treated successfully without. 
removing the clitoral sinuses. I . , 
The invention has been described herein with refer 
ence to certain preferred embodiments. However, as 
obvious variations thereon will become apparent to 
those skilled in the art, the invention is not to be consid 
ered as limited thereto. ' 
What is claimed is: . 
1. A composition for_ the treatment of contagious 
equine metritis which comprises an antimicrobial-effec 
tive amount of dextrose in an aqueous based mixture 
including a buffer present in sufficient amounts to pro 
vide a pH in the range of about 3.0 to 4.5, and a carrier, 
said composition comprising the following: 200 to 300 
parts by weight of dextrose, 40 to 110 parts by weight of 
buffer, and 80 to 110 parts by weight of a carrier, con 
tained in about a 40 to 60 weight percent concentration 
in water. _ 
2. A composition according to claim 1 which com 
prises about 200-300 parts of dextrose, about 25-75 
parts of a hydroxy carboxylic acid, about 40-110 parts 
of an alkali‘ metal salt of a-hydroxy carboxylic'acid and 
about 80-110 parts of a carrier. 
3. A composition according to claim 2 wherein the 
hydroxy polycarboxylic acid component is selected 
4,483,851 
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from the group consisting of citric acid, tartronic acid, 
malic acid, tartaric acid, and mixtures thereof. 
4. A composition according to claim 2 wherein the 
alkali metal salt of the hydroxy polycarboxylic acid is 
selected from the group consisting of sodium and potas 
sium salts of citric acid, tartronic acid, malic acid, tar 
taric acid, and mixtures thereof. 
5. A composition according to claim 2 wherein the 
carrier is a polyalkylene glycol. 
6. A composition according to claim 1 which com 
prises 250 parts dextrose, 50 parts citric acid, 25 parts 
sodium citrate, 100 ccs. glycerine and 400 005. water, 
said composition being in the form of a viscous solution 
hving a pH in the range of 3.2. 
7. A method for the treatment of contagious equine 
metritis in horses which comprises topical application 
to the external genitalia of horses of an antimicrobial 
effective amount of dextrose in an aqueous based mix 
ture including a buffer present in sufficient amounts to 
provide a pH in the range of about 3.0 to 4.5, and a 
carrier. 
8. A method according to claim 7 wherein the com 
ponents of the composition are contained in about a 
40-60 weight percent concentration in water and are 
present in the following amounts by weight: 
Ingredient Parts by Weight 
Dextrose 200-300 
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-continued 
Ingredient Parts by Weight 
Buffer 40-110 
Carrier 80-1 10. 
9. A method according to claim 8 wherein the com‘ 
position comprises about 200-300 parts of dextrose, 
about 25-75 parts of a hydroxy carboxylic acid, about 
40-110 parts of an alkali metal salt of a hydroxy carbox 
ylic acid and about 80~ll0 parts of a carrier. 
10. A method according to claim 9 wherein the hy 
droxy polycarboxylic acid component is selected from 
the group consisting of citric acid, tartronic acid, malic 
acid, tartaric acid, and mixtures thereof. 
11. A method according to claim 9 wherein the alkali 
metal salt of the hydroxy polycarboxylic acid is selected 
from the group consisting of sodium and potassium salts 
of citric acid, tartronic acid, malic acid, tartaric acid, 
and mixtures thereof. 
12. A method according to claim 9 wherein the car 
rier is a polyalkylene glycol. 
13. A method according to claim 7 wherein the com 
position comprises 250 parts dextrose, 50 parts citric 
acid, 25 parts sodium citrate, 100 ccs. glycerine and 400 
ccs. water, said composition being in the form ‘of a vis 
cous solution having a pH in the range of 3.2. 
14. A method according to claim 7 wherein the com 
position is topically applied to the external genitalia of 
the horses one time per day for at least two successive 
days. 
* t * * * 
